Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.3400
+0.0215
+(6.75%)
At close: April 4 at 4:00:02 PM EDT
0.3010
-0.04
(-11.47%)
After hours: April 4 at 7:59:28 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.77 | -0.65 | -2.16 | 0 |
| Low Estimate | -0.77 | -0.65 | -2.16 | 0 |
| High Estimate | -0.77 | -0.65 | -2.16 | 0 |
| Year Ago EPS | -1.11 | -1.01 | -3.87 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.18 | -0.98 | -1 | -0.92 |
| EPS Actual | -1.11 | -1.01 | -1.03 | -0.74 |
| Difference | 0.07 | -0.03 | -0.03 | 0.18 |
| Surprise % | 5.93% | -3.06% | -3.00% | 19.57% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.77 | -0.65 | -2.16 | 0 |
| 7 Days Ago | -0.66 | -0.55 | -2.16 | 0 |
| 30 Days Ago | -0.66 | -0.55 | -2.16 | 0 |
| 60 Days Ago | -0.66 | -0.55 | -2.16 | 0 |
| 90 Days Ago | -0.66 | -0.55 | -2.16 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PCSA | 30.63% | 35.64% | 44.19% | -- |
| S&P 500 | 6.59% | 6.64% | 9.81% | 16.08% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/5/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/20/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/1/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/12/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/13/2024 |
Related Tickers
QNRX Quoin Pharmaceuticals, Ltd.
0.2332
-10.34%
ENTO Entero Therapeutics, Inc.
0.5090
+16.48%
HEPA Hepion Pharmaceuticals, Inc.
0.4601
-4.90%
PTIX Protagenic Therapeutics, Inc.
0.3876
-7.27%
GRI GRI Bio, Inc.
1.5100
+4.86%
OSRH OSR Holdings, Inc.
1.9500
-21.05%
BDRX Biodexa Pharmaceuticals Plc
1.6900
+14.97%
GNPX Genprex, Inc.
0.3350
-22.38%
IBO Impact BioMedical Inc.
0.9627
+107.48%
APVO Aptevo Therapeutics Inc.
1.4900
-25.13%